Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Impax Laboratories Inc (IPXL)  
$6.76 0.55 (8.86%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 159,210,000
Market Cap: 1.08(B)
Last Volume: 2,204,422 Avg Vol: 2,198,299
52 Week Range: $1.78 - $6.34
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company engaging in developing, manufacturing, marketing and distributing generic and branded pharmaceutical products across an array of dosage forms and therapeutic areas. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 215
  Page 6 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Markbreiter Michael Director   •       •      –    2015-08-26 4 S $42.78 $427,800 D/D (10,000) 8,200     -
   Markbreiter Michael Director   •       •      –    2015-08-26 4 OE $6.55 $65,500 D/D 10,000 18,200     -
   Markbreiter Michael Director   •       •      –    2015-08-25 4 S $41.67 $391,656 D/D (9,399) 8,200     -
   Schlossberg Mark A SVP and General Counsel   •       •      –    2015-07-08 4 D $45.99 $180,097 D/D (3,916) 85,694     -
   Schlossberg Mark A SVP and General Counsel   •       •      –    2015-05-23 4 D $46.21 $50,923 D/D (1,102) 89,610     -
   Nestor Michael President, Impax Pharm.   •       •      –    2015-05-23 4 D $46.21 $78,372 D/D (1,696) 116,833     -
   Schlossberg Mark A SVP and General Counsel   •       •      –    2015-05-15 4 D $44.44 $103,545 D/D (2,330) 90,712     -
   Reasons Bryan M. Chief Financial Officer   •       •      –    2015-05-15 4 D $44.44 $61,816 D/D (1,391) 69,989     -
   Nestor Michael President, Impax Pharm.   •       •      –    2015-05-15 4 D $44.44 $143,808 D/D (3,236) 118,529     -
   Schlossberg Mark A SVP and General Counsel   •       •      –    2015-05-14 4 D $44.82 $96,946 D/D (2,163) 93,042     -
   Reasons Bryan M. Chief Financial Officer   •       •      –    2015-05-14 4 D $44.82 $96,856 D/D (2,161) 71,380     -
   Nornhold Jeffrey SVP, Technical Operations   •       •      –    2015-05-14 4 D $44.82 $20,931 D/D (467) 70,358     -
   Nestor Michael President, Impax Pharm.   •       •      –    2015-05-14 4 D $44.82 $134,594 D/D (3,003) 121,765     -
   Burr Robert L Director   •       •      –    2015-05-12 4 A $0.00 $0 D/D 3,100 51,725     -
   Chao Allen Director   •       •      –    2015-05-12 4 A $0.00 $0 D/D 3,100 60,695     -
   Fleming Nigel Director   •       •      –    2015-05-12 4 A $0.00 $0 D/D 3,100 14,366     -
   Pendergast Mary K Director   •       •      –    2015-05-12 4 A $0.00 $0 D/D 3,100 13,600     -
   Hsu Larry Director   •       •      –    2015-05-12 4 A $0.00 $0 D/D 3,100 58,251     -
   Terreri Peter R Director   •       •      –    2015-05-12 4 A $0.00 $0 D/D 3,100 44,620     -
   Markbreiter Michael Director   •       •      –    2015-05-12 4 A $0.00 $0 D/D 3,100 17,599     -
   Benet Leslie Z Director   •       •      –    2015-05-12 4 A $0.00 $0 D/D 1,100 9,200     -
   Nestor Michael President, Impax Pharm.   •       •      –    2015-05-11 4 D $46.10 $78,278 D/D (1,698) 124,768     -
   Wilkinson George Fred Chief Executive Officer   •       •      –    2015-04-29 4 D $46.36 $5,322,267 D/D (114,803) 459,116     -
   Reasons Bryan M. Chief Financial Officer   •       •      –    2015-04-13 4 D $50.90 $61,335 D/D (1,205) 73,541     -
   Nornhold Jeffrey SVP, Technical Operations   •       •      –    2015-04-08 4 D $51.18 $122,013 D/D (2,384) 70,825     -
  215 Records found
  1  2  3  4  5  6  7  8  9   
  Page 6 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us